Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative solutions designed to improve patient outcomes, today announced U.S. Food and Drug ...
Haemonetics received clearance from the Food and Drug Administration for its next-generation plasma collection system. The medical technology company said Monday that the FDA granted 510(k) clearance ...
(RTTNews) - Haemonetics Corp. (HAE) has received FDA clearance for advancements to its NexSys PCS plasma collection system. These include a new plasma collection bowl, featuring a patented design that ...
Haemonetics Corporation’s HAE impressive Hospital business recovery is poised to drive growth in the upcoming quarters. The robust uptake of the NexSys PCS system bodes well for its long-term growth.
Haemonetics Corporation reported strong fiscal Q1 2024 financial performance, beating estimates for non-GAAP EPS and revenue. The company's advancements in the NexSys Plasma collection system and ...
BOSTON, June 22, 2023 /PRNewswire/ -- Haemonetics Corporation (HAE), a global medical technology company focused on delivering innovative solutions to drive better patient outcomes, today announced it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results